Clinical Trials Browser

Phase 1 × Carcinoma, Endometrioid × 1 year × Clear all

NCT03875820 2026-03-10

FRAME

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Endometrioid

NCT03748186 2025-08-20

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

Phase 1 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid